COVID-19 对结核病的临床影响。

Q2 Medicine Infezioni in Medicina Pub Date : 2022-12-01 eCollection Date: 2022-01-01 DOI:10.53854/liim-3004-3

Stefano Sanduzzi Zamparelli, Mauro Mormile, Alessandro Sanduzzi Zamparelli, Amedeo Guarino, Roberto Parrella, Marialuisa Bocchino

{"title":"COVID-19 对结核病的临床影响。","authors":"Stefano Sanduzzi Zamparelli, Mauro Mormile, Alessandro Sanduzzi Zamparelli, Amedeo Guarino, Roberto Parrella, Marialuisa Bocchino","doi":"10.53854/liim-3004-3","DOIUrl":null,"url":null,"abstract":"During COVID-19 pandemic, a lot of diseases suffered from a limited access to health care services, owing to the use of resources, both technical and financial, mainly directed towards such a dramatic outbreak. Among these, tuberculosis (TB) has been one of the most penalized, with a huge delay both in diagnosis and in start of treatment, with a consequential dramatic increase in morbidity and mortality. COVID-19 and tuberculosis share similar common pathogenetic pathways, and both diseases affect primarily the lungs. About the impact of TB on COVID-19 severity and mortality, data are unclear and literature reports are often conflicting. Certainly, considering the management of coinfected patients, there are pharmacokinetic interactions between several drugs used for the therapy of SARS-CoV-2 infection and the treatment of TB.","PeriodicalId":52423,"journal":{"name":"Infezioni in Medicina","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715002/pdf/1124-9390_30_4_2022_495-500.pdf","citationCount":"0","resultStr":"{\"title\":\"Clinical impact of COVID-19 on tuberculosis.\",\"authors\":\"Stefano Sanduzzi Zamparelli, Mauro Mormile, Alessandro Sanduzzi Zamparelli, Amedeo Guarino, Roberto Parrella, Marialuisa Bocchino\",\"doi\":\"10.53854/liim-3004-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"During COVID-19 pandemic, a lot of diseases suffered from a limited access to health care services, owing to the use of resources, both technical and financial, mainly directed towards such a dramatic outbreak. Among these, tuberculosis (TB) has been one of the most penalized, with a huge delay both in diagnosis and in start of treatment, with a consequential dramatic increase in morbidity and mortality. COVID-19 and tuberculosis share similar common pathogenetic pathways, and both diseases affect primarily the lungs. About the impact of TB on COVID-19 severity and mortality, data are unclear and literature reports are often conflicting. Certainly, considering the management of coinfected patients, there are pharmacokinetic interactions between several drugs used for the therapy of SARS-CoV-2 infection and the treatment of TB.\",\"PeriodicalId\":52423,\"journal\":{\"name\":\"Infezioni in Medicina\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715002/pdf/1124-9390_30_4_2022_495-500.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infezioni in Medicina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53854/liim-3004-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infezioni in Medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53854/liim-3004-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在 COVID-19 大流行期间，由于技术和财政资源的使用主要是为了应对如此严重的疫情，许多疾病的医疗服务受到限制。其中，肺结核（TB）是受影响最严重的疾病之一，无论是诊断还是开始治疗都出现了严重的延误，导致发病率和死亡率急剧上升。COVID-19 和肺结核有着相似的共同致病途径，而且这两种疾病都主要影响肺部。关于结核病对 COVID-19 严重程度和死亡率的影响，目前尚无明确数据，文献报道也往往相互矛盾。当然，考虑到对合并感染患者的管理，用于治疗 SARS-CoV-2 感染的几种药物与治疗结核病的药物之间存在药代动力学相互作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Clinical impact of COVID-19 on tuberculosis.

During COVID-19 pandemic, a lot of diseases suffered from a limited access to health care services, owing to the use of resources, both technical and financial, mainly directed towards such a dramatic outbreak. Among these, tuberculosis (TB) has been one of the most penalized, with a huge delay both in diagnosis and in start of treatment, with a consequential dramatic increase in morbidity and mortality. COVID-19 and tuberculosis share similar common pathogenetic pathways, and both diseases affect primarily the lungs. About the impact of TB on COVID-19 severity and mortality, data are unclear and literature reports are often conflicting. Certainly, considering the management of coinfected patients, there are pharmacokinetic interactions between several drugs used for the therapy of SARS-CoV-2 infection and the treatment of TB.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Infezioni in Medicina Medicine-Infectious Diseases

CiteScore

8.40

自引率

0.00%

发文量

期刊介绍： The Journal publishes original papers, in Italian or in English, on topics concerning aetiopathogenesis, prevention, epidemiology, diagnosis, clinical features and therapy of infections, whose acceptance is subject to the referee’s assessment. The Journal is of interest not only to infectious disease specialists, microbiologists and pharmacologists, but also to internal medicine specialists, paediatricians, pneumologists, and to surgeons as well. The Editorial Board includes experts in each of the above mentioned fields.